Last reviewed · How we verify
Tafamidis 61 mg free acid tablet (Test) (tafamidis-61-mg-free-acid-tablet-test)
Tafamidis 61 mg free acid tablet (Test) (generic name: tafamidis-61-mg-free-acid-tablet-test) is a drug developed by Pfizer Inc.. It is currently in Phase 1 development.
At a glance
| Generic name | tafamidis-61-mg-free-acid-tablet-test |
|---|---|
| Sponsor | Pfizer Inc. |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study to Compare Two Forms of Study Medicine Tafamidis in the Blood in Healthy Adults (PHASE1)
- A Study to Learn How Different Forms of Study Medicine Tafamidis Are Taken Up Into The Blood in Healthy Adults (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tafamidis 61 mg free acid tablet (Test) CI brief — competitive landscape report
- Tafamidis 61 mg free acid tablet (Test) updates RSS · CI watch RSS
- Pfizer Inc. portfolio CI
Frequently asked questions about Tafamidis 61 mg free acid tablet (Test)
What is Tafamidis 61 mg free acid tablet (Test)?
Tafamidis 61 mg free acid tablet (Test) (tafamidis-61-mg-free-acid-tablet-test) is a pharmaceutical drug developed by Pfizer Inc..
Who makes Tafamidis 61 mg free acid tablet (Test)?
Tafamidis 61 mg free acid tablet (Test) is developed by Pfizer Inc. (see full Pfizer Inc. pipeline at /company/pfizer).
What is the generic name of Tafamidis 61 mg free acid tablet (Test)?
tafamidis-61-mg-free-acid-tablet-test is the generic (nonproprietary) name of Tafamidis 61 mg free acid tablet (Test).
What development phase is Tafamidis 61 mg free acid tablet (Test) in?
Tafamidis 61 mg free acid tablet (Test) is in Phase 1.